Dendritic NanoTechnologies' Founder to Present Today at FDA Center for Drug Evaluation and Research Dr. Tomalia Helps FDA Scientists Better Understand Nanotechnology and Prepare

for Forthcoming FDA Review of Nanotechnology-Based Therapies



    MOUNT PLEASANT, Mich., March 24 /PRNewswire/ -- Dr. Donald Tomalia, the
 founder of Dendritic NanoTechnologies Inc. (DNT), is presenting today at a
 two-day workshop being held by the Federal Drug Administration. Dr. Tomalia
 will kick off today's workshop with a presentation titled:  "Dendrimer-Based
 Nanotechnology: Its Impact on Biology, Pharma Delivery, MRI Imaging and


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.